All
In Interim Analysis, Mogamulizumab Demonstrates Improvements In Mycosis Fungoides, Sézary Syndrome
Interim findings from the PROSPER study of mogamulizumab in adults with CTCL were recently presented orally.
FDA Issues Alert on Counterfeit Botox: What Dermatology Clinicians Need to Know
The FDA has released guidelines for clinicians and tips to identify the distinguishing features of counterfeit products.
New AAD Atopic Dermatitis Guidelines and Dupilumab Label Updates
Five experts delved into the latest updates to treatment guidelines and the updated label use for dupilumab for hand-foot AD.
Reviewing the Rosacea Pipeline: A Look at the Last 10 Years
In recognition of Rosacea Awareness Month, Dermatology Times is reviewing research and strides in rosacea treatment over the last decade.
Is Your Texting as Caring as Your Bedside Manner?
Test your knowledge to see if your patients would consider you an efficient texter.
Dermatology Residency Programs Lack Specific, Comprehensive Education on Sensitive Skin
Research from the GW School of Medicine and Health Sciences was recently published in the Journal of Drugs in Dermatology.
Partner Q&A: Spherix Global Insights' Role in Shaping the Future of Dermatology
Dermatology Times is pleased to introduce one of our newest partners, Spherix Global Insights. Learn more about their vision and plans to leverage knowledge to support dermatology.
My Colleague Has Defamed Me Online: What Can I Do?
What are your rights in the instance a colleague defames you online or on social media? David Goldberg, MD, JD, shares legal advice in our April issue.
QUIZ: Test Your Knowledge of Rosacea Complications and Comorbidities
Click here to read more and answer our quiz questions in recognition of Rosacea Awareness Month.
Derm In The News: April 7-13
Keep up with the latest headlines in dermatology from the past week, including UK efforts to address skin cancer disparities in skin of color, efficacy of a "virtual biopsy," and more.
The Weekly Roundup: April 8-12
ICYMI, this week we had news about Rosacea Awareness Month, topical pravibismane in diabetic foot ulcer infections, and more.
Surface Area of IL-23's Epitope Influences Short- and Long-Term Responses for IL-23 Inhibitors in Plaque Psoriasis
Risankizumab demonstrated the highest efficacy in PASI90 responses among analyzed IL-23 inhibitors.
QUIZ RECAP: Test Your Knowledge of Rosacea Etiology, Types, and Triggers
Earlier this week, we shared our first Rosacea Awareness Month quiz. Review the answers and your responses below.
Treatment With Tralokinumab Improved Epidermal Pathology, Reduced Systemic Markers In Type 2 Inflammation
Treatment also shifted the expression of key biomarkers in atopic dermatitis toward non-lesional levels, according to a recent study.
Tax-Loss Harvesting: An Important Tactic Every Dermatologist Should Consider
To properly execute loss harvesting and reinvestment properly, without running afoul of Internal Revenue Service rules, it is crucial that one works with a professional adviser experienced in these matters.
Rosacea Roundup: The Year so Far
This Rosacea Awareness Month, take a look at previous coverage from 2024.
Comparison of Psoriatic Arthritis Therapies Finds Bimekizumab More Effective Than Guselkumab
A matching-adjusted indirect comparison found that some patients with PsA are more likely to achieve long-term treatment outcomes with bimekizumab.
Probiotics Cannot Replace Standard of Care Atopic Dermatitis Therapies, Research Letter Argues
In one study, researchers were unable to detect any changes in the gut microbiome of patients treated with tapering dose of steroids or a probiotic mixture.
Reflectance Confocal Microscopy Enhances Detection Sensitivity for Flat Amelanotic/Hypomelanotic Melanoma Differential Diagnosis
Diagnostic accuracy of lesions was enhanced with combined dermoscopy and reflectance confocal microscopy, according to one study.
Neurocosmetics: Sensates and Smells on the Skin
Zoe Diana Draelos, MD, provides answers to the top 5 questions about neurocosmetics patients may have.
Shanna Miranti, MPAS, PA-C, Shares Highlights From Diversity in Dermatology Meeting
Miranti presented tips on handling denial hurdles and how to ensure patients receive access to the treatments they need.
Study Becomes First to Demonstrate Efficacy of Topical Isoniazid in Melasma
Study participants in the treatment group experienced an observable and significant decrease in melanin index scoring.
Benzene Found in Benzoyl Peroxide-Containing Acne Products: What Comes Next?
From our April cover feature: Take an in-depth look at the basis of Valisure's benzene testing methods and practical recommendations for clinicians from Christopher Bunick, MD, PhD.
Fire Needle Combined With Excimer Laser Safe, Effective Therapy for Vitiligo, Review Finds
Combining fire needle therapy with a 308 nm excimer laser for vitiligo treatment, as per a recent meta-analysis, was deemed both safe and effective.
MoonLake Immunotherapeutics and Komodo Health to Partner to Improve Research on Inflammatory Skin Conditions
MoonLake’s sonelokimab is being evaluated for hidradenitis suppurativa, psoriasis, and psoriatic arthritis.
Allergan Aesthetics Launches 2 Products For Acne-Prone Skin
Mona Gohara, MD, explained the importance of the products' impact on the skin barrier.
CP-GEP Model Successful in Stratifying Node-Negative Patients into Risk Groups for Melanoma Disease Progression
According to 2 studies, this model has demonstrated the potential to assist in developing treatment and monitoring plans for early-stage melanomas.
Apremilast Demonstrates Consistent Safety and Efficacy in Children with Moderate to Severe Plaque Psoriasis at 52 Weeks
Loretta Fiorillo, MD, FRCPC, reviews key data points from the phase 3 SPROUT study.
Meet the Spring Editor in Chief: Aaron Farberg, MD
Dermatology Times is pleased to introduce our Spring Editor in Chief, Aaron Farberg, MD, with a snapshot of his involvement in the dermatology space.
Rosacea Awareness Month: Resources to Share With Your Patients
This Rosacea Awareness Month, we have compiled a list of resources for clinicians to share with their rosacea patients.